Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

ClinicalTrials.gov ID: NCT00228605

Public ClinicalTrials.gov record NCT00228605. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label 12 Month Study to Evaluate the Safety, Tolerability and Efficacy of OraVescent Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Noncancer Pain

Study identification

NCT ID
NCT00228605
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

  • OraVescent Fentanyl Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2005
Primary completion
Not listed
Completion
Apr 30, 2007
Last update posted
May 8, 2014

2005 – 2007

United States locations

U.S. sites
38
U.S. states
23
U.S. cities
32
Facility City State ZIP Site status
MedSearch Calera Alabama 35040
Clinical Research Consultants, Inc. Hoover Alabama 35216
Arizona Research Center Phoenix Arizona 85023
NEA Clinic Jonesboro Arkansas 72404
Lynn Institute of the Rockies Colorado Springs Colorado 80909
Radiant Research-Daytona Beach Daytona Beach Florida 32114
Advent Clinical Research Centers, Inc. St. Petersburg Florida 33703
Gold Coast Research Weston Florida 33331
Center for Prospective Outcome Studies, Inc. Atlanta Georgia 30327
Advent Clinical Research Centers, Inc. Atlanta Georgia 30342
Center for Prospective Outcome Studies, Inc. Marietta Georgia 30060
North Fulton Regional Hospital Pain Center Roswell Georgia 30076
Carmen Research Smyrna Georgia 30080
Orthopedic Health Care Boise Idaho 83702
Medisphere Medical Research Center, LLC Evansville Indiana 47714
Tri-State Arthritis & Rheumatology Center, LLC Evansville Indiana 47714
Iowa Pain Management Clinic, PC Des Moines Iowa 50265
Mid-America Physiatrists, PA Overland Park Kansas 66211
Capital Clinical Research Associates, LLC Rockville Maryland 20852
Brigham Women's Hospital, Attn: Pain Trials Center Boston Massachusetts 02115
MedVadis Research Wellesley Hills Massachusetts 02481-2106
Medex Healthcare Research Center St Louis Missouri 63108
Radiant Research - St. Louis St Louis Missouri 63141
Clinical Research Center of Nevada Las Vegas Nevada 89104
Northshore University Hospital Bethpage New York 11714
NYU Pain Management Center New York New York 10016
Research Across America New York New York 10022
The Lynn Health Science Institute Oklahoma City Oklahoma 73112
Southern Oregon Health & Wellness Medford Oregon 97504
Clinical Research Center of Reading, LLP West Reading Pennsylvania 19611
Healthstar Physicians Morristown Tennessee 37813
Biopharma Research Associates Sugar Land Texas 77479
Lifetree Clinical Research Salt Lake City Utah 84106
Radiant Research Salt Lake City Utah 84107
Huntsman Cancer Institute Salt Lake City Utah 84112
Pain Management Center South Burlington Vermont 05403
Northwest Clinical Research Center Bellevue Washington 98004
Rowan Research Spokane Washington 99207

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00228605, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 8, 2014 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00228605 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →